139 related articles for article (PubMed ID: 3890574)
21. [Variability of in vitro activity of proguanil and cycloguanil on erythrocyte stages of Plasmodium falciparum as a function of culture conditions].
Ndounga M; Basco LK; Ringwald P
Bull Soc Pathol Exot; 1999 Dec; 92(5):313-6. PubMed ID: 10690466
[TBL] [Abstract][Full Text] [Related]
22. [Presence of pyrimethamine and cycloguanil resistance genotype in West Africa? Evidence of a single mutation 59Arg in the dhfr gene of Plasmodium falciparum].
Pinheiro L; Rosário VE
Acta Med Port; 2003; 16(4):235-8. PubMed ID: 22226208
[TBL] [Abstract][Full Text] [Related]
23. In vitro susceptibility studies of Plasmodium falciparum isolates and clones against type II antifolate drugs.
Ang HH; Lam CK; Wah MJ
Chemotherapy; 1996; 42(5):318-23. PubMed ID: 8874969
[TBL] [Abstract][Full Text] [Related]
24. Infectivity of Plasmodium falciparum gametocytes to Anopheles arabiensis after treatment with sulfadoxine-pyrimethamine.
Govere JM; Durrheim DN; Mngomezulu NM; Barnes K; Sharp B
Trans R Soc Trop Med Hyg; 2003; 97(6):707-8. PubMed ID: 16117968
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic and sporontocidal treatment of chloroquine resistant Plasmodium falciparum from Malaya.
Clyde DF; DuPont HL; Miller RM; McCarthy VC
Trans R Soc Trop Med Hyg; 1970; 64(6):834-8. PubMed ID: 4924648
[No Abstract] [Full Text] [Related]
26. Susceptibility studies of Malaysian Plasmodium falciparum clones to type II antifolate drugs after 3 years of continuous in vitro culture.
Ang HH; Cheang HS; Mak JW
Chemotherapy; 2005 Oct; 51(6):377-80. PubMed ID: 16227695
[TBL] [Abstract][Full Text] [Related]
27. Effects of folic and folinic acids in the activities of cycloguanil and WR99210 against Plasmodium falciparum in erythrocytic culture.
Yeo AE; Seymour KK; Rieckmann KH; Christopherson RI
Ann Trop Med Parasitol; 1997 Jan; 91(1):17-23. PubMed ID: 9093425
[TBL] [Abstract][Full Text] [Related]
28. Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil.
Fidock DA; Wellems TE
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10931-6. PubMed ID: 9380737
[TBL] [Abstract][Full Text] [Related]
29. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase.
Hekmat-Nejad M; Rathod PK
Exp Parasitol; 1997 Nov; 87(3):222-8. PubMed ID: 9371087
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the susceptibility of Plasmodium knowlesi and Plasmodium falciparum to antimalarial agents.
van Schalkwyk DA; Moon RW; Blasco B; Sutherland CJ
J Antimicrob Chemother; 2017 Nov; 72(11):3051-3058. PubMed ID: 28961865
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility studies of Plasmodium falciparum isolates and clones against cycloguanil and pyrimethamine using the modified in vitro microtechnique.
Ang HH; Chan KL; Mak JW
J Parasitol; 1996 Dec; 82(6):1029-31. PubMed ID: 8973418
[TBL] [Abstract][Full Text] [Related]
32. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
Méndez F; Herrera S; Murrain B; Gutiérrez A; Moreno LA; Manzano M; Muñoz A; Plowe CV
Am J Trop Med Hyg; 2007 Sep; 77(3):438-43. PubMed ID: 17827356
[TBL] [Abstract][Full Text] [Related]
33. Plasmodium falciparum malaria: rosettes are disrupted by quinine, artemisinin, mefloquine, primaquine, pyrimethamine, chloroquine and proguanil.
Goldring JD; Padayachee T; Ismail I
Mem Inst Oswaldo Cruz; 1999; 94(5):667-74. PubMed ID: 10464415
[TBL] [Abstract][Full Text] [Related]
34. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea.
Reeder JC; Rieckmann KH; Genton B; Lorry K; Wines B; Cowman AF
Am J Trop Med Hyg; 1996 Aug; 55(2):209-13. PubMed ID: 8780462
[TBL] [Abstract][Full Text] [Related]
35. The activity in vitro of cycloguanil and pyrimethamine in combination against Plasmodium falciparum.
Yeo AE; Rieckmann KH
Trans R Soc Trop Med Hyg; 1992; 86(3):234. PubMed ID: 1412640
[No Abstract] [Full Text] [Related]
36. Gametocytocidal and sporontocidal activity of antimalarials against Plasmodium berghei ANKA in ICR Mice and Anopheles stephensi mosquitoes.
Coleman RE; Clavin AM; Milhous WK
Am J Trop Med Hyg; 1992 Feb; 46(2):169-82. PubMed ID: 1539752
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo susceptibility of Plasmodium falciparum isolates from Liberia to pyrimethamine, cycloguanil and chlorcycloguanil.
Petersen E; Hogh B; Hanson AP; Bjorkman A; Flacks H
Ann Trop Med Parasitol; 1990 Dec; 84(6):563-71. PubMed ID: 2076034
[TBL] [Abstract][Full Text] [Related]
38. Synergistic antimalarial activity of dapsone/dihydrofolate reductase inhibitors and the interaction of antifol, antipyrimidine and antipurine combinations against Plasmodium falciparum in vitro.
Scott HV; Rieckmann KH; O'Sullivan WJ
Trans R Soc Trop Med Hyg; 1987; 81(5):715-21. PubMed ID: 3329779
[TBL] [Abstract][Full Text] [Related]
39. Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates.
Pradines B; Spiegel A; Rogier C; Tall A; Mosnier J; Fusai T; Trape JF; Parzy D
Am J Trop Med Hyg; 2000 Jan; 62(1):82-5. PubMed ID: 10761729
[TBL] [Abstract][Full Text] [Related]
40. A rabbit--in vitro system to evaluate drug action against Plasmodium falciparum.
Mrema JE; Rieckmann KH
Trans R Soc Trop Med Hyg; 1983; 77(1):130-5. PubMed ID: 6222522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
